EUDA Health Announces Second Amendment to Streeterville Warrant Agreement

Key Takeaways:

• EUDA Health is a non-invasive healthcare provider in Asia.
• The company focuses on Singapore, Malaysia, and China.
• It is listed on NASDAQ under the ticker EUDA.
• EUDA announced a second amendment to its existing Streeterville warrant agreement.
• The latest development shapes its strategic investments in key Asian markets.

Background on EUDA Health

EUDA Health Holdings Limited, trading on NASDAQ under the symbol “EUDA,” is headquartered in Singapore. The company focuses on non-invasive healthcare solutions and has targeted growth within Singapore, Malaysia, and China. This regionally tailored approach underscores EUDA’s commitment to offering specialized healthcare that meets the diverse needs of patients across Asia.

The Second Amendment Announcement

On January 15, 2026, EUDA Health announced it had entered into a second amendment to its previously disclosed warrant agreement with Streeterville Capital, LLC. Although specific details of the amendment are not publicly provided in this announcement, the change indicates a continued partnership between EUDA and Streeterville, setting the stage for potential shifts in EUDA’s equity or investment strategies.

Significance for Regional Healthcare

The warrant agreement amendment illustrates EUDA’s intent to adapt and refine its financial arrangements, potentially paving the way for greater alignment of resources. With a rapidly evolving healthcare environment in Asia, establishing robust financial foundations can enable healthcare providers like EUDA to offer advanced, non-invasive medical services effectively.

Broader Focus on Partnerships

Partnerships and investor relationships remain central to EUDA’s expansion. By revisiting and revising the terms of its warrant agreement, the company demonstrates its capacity to respond to market changes and maintain strong ties with key stakeholders. As demand for innovative healthcare solutions continues to grow in Singapore, Malaysia, and China, the Streeterville agreement may play a role in supporting EUDA’s strategic investments.

Looking Ahead

While the full implications of this latest amendment are yet to be seen, EUDA Health’s decision signals a forward-thinking approach. By reinforcing its existing investor connections, the company sets the stage for further development and expansion within Asia’s dynamic healthcare markets.